Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Risk of recurrent ischemic stroke in young cryptogenic patients with embolic stroke of undetermined source

D. Šaňák, P. Divišová, M. Hutyra, M. Král, A. Bártková, J. Zapletalová, J. Látal, T. Dorňák, Š. Hudec, D. Franc, P. Polidar, T. Veverka, P. Kaňovský

. 2020 ; 416 (-) : 116985. [pub] 20200613

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21020124

Grantová podpora
NV17-30101A MZ0 CEP - Centrální evidence projektů

INTRODUCTION: Elderly cryptogenic ischemic stroke (IS) patients with embolic stroke of undetermined source (ESUS) have a high risk of recurrent IS (RIS) compared to other stroke subtypes. In young ESUS patients, different sources of embolism may be a cause and the risk of RIS remains not enough established. The aim was to assess and compare risk of RIS between ESUS and non ESUS patients <50 years. METHODS: The study set consisted of young acute IS patients <50 years enrolled in the prospective HISTORY (Heart and Ischemic STrOke Relationship studY) study registered on ClinicalTrials.gov (NCT01541163). In all analyzed patients, the brain ischemia was confirmed on CT or MRI. All patients underwent identical diagnostic protocol including TEE and long-term ECG-Holter. Cause of IS was assessed according to the ASCOD classification. RESULTS: Of 320 enrolled patients <50 years, 219 (68.4%) were identified as cryptogenic (119 males, mean age 41.4 ± 7.2 years) and 122 (38.1%) patients fulfilled the ESUS criteria. During the follow-up with a median of 34 months, three (2.5%) ESUS and 5 (5.2%) non-ESUS patients suffered from RIS (p = .471). One-year risk of RIS was 0.008 (95% CI: 0-0.025) for ESUS and 0.036 (95% CI: 0-0.076) for non-ESUS patients (p = .262). CONCLUSION: The risk of RIS was very low in ESUS patients and did not differ from those with non-ESUS. Our finding may indicate that antiplatelet therapy can be effective in the secondary prevention in young ESUS patients if high-risk sources of embolization are excluded extensively.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020124
003      
CZ-PrNML
005      
20211123082423.0
007      
ta
008      
210728s2020 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jns.2020.116985 $2 doi
035    __
$a (PubMed)32563078
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Šaňák, Daniel $u Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic. Electronic address: daniel.sanak@fnol.cz
245    10
$a Risk of recurrent ischemic stroke in young cryptogenic patients with embolic stroke of undetermined source / $c D. Šaňák, P. Divišová, M. Hutyra, M. Král, A. Bártková, J. Zapletalová, J. Látal, T. Dorňák, Š. Hudec, D. Franc, P. Polidar, T. Veverka, P. Kaňovský
520    9_
$a INTRODUCTION: Elderly cryptogenic ischemic stroke (IS) patients with embolic stroke of undetermined source (ESUS) have a high risk of recurrent IS (RIS) compared to other stroke subtypes. In young ESUS patients, different sources of embolism may be a cause and the risk of RIS remains not enough established. The aim was to assess and compare risk of RIS between ESUS and non ESUS patients <50 years. METHODS: The study set consisted of young acute IS patients <50 years enrolled in the prospective HISTORY (Heart and Ischemic STrOke Relationship studY) study registered on ClinicalTrials.gov (NCT01541163). In all analyzed patients, the brain ischemia was confirmed on CT or MRI. All patients underwent identical diagnostic protocol including TEE and long-term ECG-Holter. Cause of IS was assessed according to the ASCOD classification. RESULTS: Of 320 enrolled patients <50 years, 219 (68.4%) were identified as cryptogenic (119 males, mean age 41.4 ± 7.2 years) and 122 (38.1%) patients fulfilled the ESUS criteria. During the follow-up with a median of 34 months, three (2.5%) ESUS and 5 (5.2%) non-ESUS patients suffered from RIS (p = .471). One-year risk of RIS was 0.008 (95% CI: 0-0.025) for ESUS and 0.036 (95% CI: 0-0.076) for non-ESUS patients (p = .262). CONCLUSION: The risk of RIS was very low in ESUS patients and did not differ from those with non-ESUS. Our finding may indicate that antiplatelet therapy can be effective in the secondary prevention in young ESUS patients if high-risk sources of embolization are excluded extensively.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    12
$a ischemie mozku $x komplikace $x diagnostické zobrazování $x epidemiologie $7 D002545
650    12
$a embolická cévní mozková příhoda $7 D000083262
650    _2
$a lidé $7 D006801
650    12
$a intrakraniální embolie $x komplikace $x diagnostické zobrazování $x epidemiologie $7 D020766
650    12
$a ischemická cévní mozková příhoda $7 D000083242
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prospektivní studie $7 D011446
650    _2
$a rizikové faktory $7 D012307
650    12
$a cévní mozková příhoda $x diagnostické zobrazování $x epidemiologie $x etiologie $7 D020521
655    _2
$a časopisecké články $7 D016428
700    1_
$a Divišová, Petra $u Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic $7 xx0266700
700    1_
$a Hutyra, Martin $u Department of Cardiology, Palacký University Medical School and Hospital, Olomouc, Czech Republic
700    1_
$a Král, Michal $u Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic
700    1_
$a Bártková, Andrea $u Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic
700    1_
$a Zapletalová, Jana $u Department of Biophysics and statistics, Palacký University Medical School, Olomouc, Czech Republic
700    1_
$a Látal, Jan $u Department of Cardiology, Palacký University Medical School and Hospital, Olomouc, Czech Republic
700    1_
$a Dorňák, Tomáš $u Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic
700    1_
$a Hudec, Štěpán $u Department of Cardiology, Palacký University Medical School and Hospital, Olomouc, Czech Republic
700    1_
$a Franc, David $u Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic
700    1_
$a Polidar, Petr $u Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic
700    1_
$a Veverka, Tomáš $u Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic
700    1_
$a Kaňovský, Petr $u Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic
773    0_
$w MED00003004 $t Journal of the neurological sciences $x 1878-5883 $g Roč. 416, č. - (2020), s. 116985
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32563078 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20211123082424 $b ABA008
999    __
$a ok $b bmc $g 1690834 $s 1140570
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 416 $c - $d 116985 $e 20200613 $i 1878-5883 $m Journal of the neurological sciences $n J Neurol Sci $x MED00003004
GRA    __
$a NV17-30101A $p MZ0
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...